ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 135 filers reported holding ARCUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 4.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,215,617 | -9.0% | 457,695 | +3.0% | 0.01% | -14.3% |
| Q2 2023 | $9,024,171 | +243.0% | 444,322 | +207.2% | 0.01% | +250.0% |
| Q1 2023 | $2,631,273 | -12.0% | 144,637 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,990,823 | -19.7% | 144,624 | +1.6% | 0.00% | -33.3% |
| Q3 2022 | $3,725,000 | +3.2% | 142,400 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,608,000 | -2.9% | 142,367 | +20.9% | 0.00% | 0.0% |
| Q1 2022 | $3,715,000 | -20.7% | 117,715 | +1.7% | 0.00% | 0.0% |
| Q4 2021 | $4,687,000 | +399.7% | 115,804 | +330.5% | 0.00% | +200.0% |
| Q3 2021 | $938,000 | +273.7% | 26,900 | +194.8% | 0.00% | – |
| Q2 2021 | $251,000 | -72.0% | 9,124 | -71.4% | 0.00% | -100.0% |
| Q1 2021 | $895,000 | +73.4% | 31,861 | +60.4% | 0.00% | – |
| Q4 2020 | $516,000 | +46.6% | 19,859 | -39.3% | 0.00% | – |
| Q4 2018 | $352,000 | – | 32,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |